Dual-energy X-ray absorptiometry (DXA) is generally a very useful tool for assessing bone mineral density (BMD) and fracture risk. However, observational studies have shown that in certain instances, BMD as measured by DXA systematically over- or underestimates fracture risk.
https://www.ncbi.nlm.nih.gov/pubmed/27214295
Endocr Pract. 2016 Aug;22(8):990-8. doi: 10.4158/EP151019.RA. Epub 2016 May 23.
Indication For Use and Safety Information
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
Like with any percutaneous procedure, there is a small risk of infection. The sale, distribution, and use of the OsteoProbe are restricted to prescription use. Federal law (United States of America) restricts this device to use by, or on the order of, a physician.
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy
This website uses cookies to enhance the user experience. By using this site you agree to our privacy policy